Brainstorms

950 The Prefrontal Cortex Is Out of Tune in Attention-Deficit/Hyperactivity Disorder

Stephen M. Stahl

[PDF]

Original Articles

952 The Maudsley Staging Method for Treatment-Resistant Depression: Prediction of Longer-Term Outcome and Persistence of Symptoms

Abebaw Fekadu, Sarah C. Wooderson, Kalypso Markopoulou, and Anthony J. Cleare

[Abstract] [PDF]

958 Comparison of Pharmacokinetic Profiles of Brand-Name and Generic Formulations of Citalopram and Venlafaxine: A Crossover Study

Franck Chenu, Lisa A. Batten, Gerald Zernig, Elisabeth Ladstaetter, Chantal Hébert, and Pierre Blier

[Abstract] [PDF]

967 Clinical Usefulness of the Diagnostic Manual-Intellectual Disability for Mental Disorders in Persons With Intellectual Disability: Results From a Brief Field Survey

Robert J. Fletcher, Susan M. Havercamp, Steven L. Ruedrich, Betsey A. Benson, L. Jarrett Barnhill, Sally Ann Cooper, and Chrissoula Stavrakaki

[Abstract] [PDF]

975 How Dosing of Ziprasidone in a State Hospital System Differs From Product Labeling

Leslie Citrome, Ari Jaffe, and Jerome Levine

[Abstract] [PDF]

983 The Importance of Childhood Trauma and Childhood Life Events for Chronicity of Depression in Adults [CME]

Jenneke E. Wiersma, Jacqueline G. F. M. Hovens, Patricia van Oppen, Erik J. Giltay, Digna J. F. van Schaik, Aartjan T. F. Beekman, and Brenda W. J. H. Penninx

[Abstract] [PDF]

990 Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

Jean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M. Kulkarni, Bruce J. Kinon, Virginia Stauffer, Sara E. Edwards, Lei Chen, David H. Adams, Haya Ascher-Svanum, Peter F. Buckley, Leslie Citrome, and Jan Volavka

[Abstract] [PDF]

997 Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis

Swapna K. Verma, Mythily Subramaniam, Alvin Liew, and Lye Yin Poon

[Abstract] [PDF]

1001 Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study of 76 Patients

Nienke C. C. Vulink, Damiaan Denys, Sjoerd B. A. H. A. Fluitman, Jantien C. M. Meinardi, and Herman G. M. Westenberg

[Abstract] [PDF]

1009 A Randomized, Double-Blind, Placebo-Controlled Study of Testosterone Treatment in Hypogonadal Older Men With Subthreshold Depression (Dysthymia or Minor Depression)

Molly M. Shores, Daniel R. Kivlahan, Tatiana I. Sadak, Ellen J. Li, and Alvin M. Matsumoto

[Abstract] [PDF]

1017 Treatment Nonadherence and Neurocognitive Impairment in Bipolar Disorder

Anabel Martinez-Aran, Jan Scott, Francesc Colom, Carla Torrent, Rafael Tabares-Seisdedos, Claire Daban, Marion Leboyer, Chantal Henry, Guy M. Goodwin, Ana Gonzalez-Pinto, Nuria Cruz, Jose Sanchez-Moreno, and Eduard Vieta

[Abstract] [PDF]

Early Career Psychiatrists

1024 Location, Location Location: The Role of Place in Career Development

Marlene P. Freeman

[PDF]

1026 Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study

Noah S. Philip, Linda L. Carpenter, Audrey R. Tyrka, Laura B. Whiteley, and Lawrence H. Price

[Abstract] [PDF]

1032 Correlates of Historical Suicide Attempt in Rapid-Cycling Bipolar Disorder: A Cross-Sectional Assessment

Keming Gao, Bryan K. Tolliver, David E. Kemp, Stephen J. Ganocy, Sarah Bilali, Kathleen L. Brady, Robert L. Findling, and Joseph R. Calabrese

[Abstract] [PDF]

1041 Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review

Viktoria Simon, Ruud van Winkel, and Marc De Hert

[Abstract] [PDF]

1051 Commentary: Three (Ancient) Questions for the Academic Psychiatrist

Michael W. Kahn

[PDF]

ASCP Corner

1052 Suicide Risk and Psychopharmacology: Assessment and Management of Acute and Chronic Risk Factors

Scott A. Freeman

[PDF]

Letters To the Editor

1054 Ziprasidone-Induced Angioedema: A Case Report

Titus Mohan, Tarun Bastiampillai, and Rohan Dhillon

[PDF]

1054 Effects of Bupropion Augmentation in Escitalopram-Resistant Patients With Major Depressive Disorder: An Open-Label, Naturalistic Study

Eduard Maron, Triin Eller, Veiko Vasar, and David J. Nutt

[PDF]

1056 Pseudohallucinations Versus True Hallucinations in Prodromal Psychosis: Does It Really Matter?

Paolo Fusar-Poli, Oliver D. Howes, and Philip McGuire

[PDF]

1057 A 5-Year Follow-Up of Diabetes Knowledge in Persons With Serious Mental Illness and Type 2 Diabetes

Faith B. Dickerson, Julie Kreyenbuhl, Richard W. Goldberg, LiJuan Fang, Deborah Medoff, Clayton H. Brown, and Lisa Dixon

[PDF]

1058 Aripiprazole Treatment of Risperidone-Induced Hyperprolactinemia

Jing Xu Chen, Yun Ai Su, Shao Li Wang, Qing Tao Bian, Yan Hong Liu, Ning Wang, Fu De Yang, Colin Haile, Thomas R. Kosten, and Xiang Yang Zhang

[PDF]

Book Reviews

1060 Recognition and Prevention of Major Mental and Substance Use Disorders

Dan G. Blazer

[PDF]

1060 The Hypomania Handbook: The Challenge of Elevated Mood

Matthew A. Becker

[PDF]

1061 Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-V

James H. Shore

[PDF]

Electronic CME Activities

Available through www.psychiatrist.com/toc

e21 Beyond Acute Treatment of Depressive Disorders

Mark Hyman Rapaport

[Abstract]

e22 Evidence-Based Treatment Paradigms for Depressed Patients With Pain and Physical Symptoms

David A. Fishbain

[Abstract]

e23 Managing Weight Gain in Patients With Severe Mental Illness

Roger S. McIntyre

[Abstract]

e24 Partial Responders to Antidepressant Treatment: Switching Strategies

Maurizio Fava

[Abstract]

e25 Managing Depression During Pregnancy

Marlene P. Freeman

[Abstract]